TRANSPLANTATION CD24 hi CD27 1 and plasmablast-like regulatory B cells in human chronic graft-versus-host disease

pathogenesis of chronic graft-versus-host disease (cGVHD) after allogeneic stem cell transplantation. Here, we found a relation between decreased Breg frequencies and cGVHD severity. An impaired ability of B cells to produce IL-10, possibly linked to poor signal transducer and activator of transcription 3 and extracellular signal-regulated kinase phosphorylation, was found in patients with active cGVHD. IL-10 production was not confined toasingleB-cellsubset,but enriched inboththeCD24 hi CD27 1 andCD27 hi CD38 hi plasmablast B-cell compartments. In vitro plasmablast differentiation increased the frequency of IL-10–producing B cells. We confirmed that allogeneic transplant recipients had an impaired reconstitution of the memory B-cellpool.cGVHDpatientshadlessCD24 hi CD27 1 BcellsandIL-10–producingCD24 hi CD27 1 Bcells.PatientswithcGVHDhadincreased plasmablast frequencies but decreased IL-10–producing plasmablasts. These results suggest a role of CD24 hi CD27 1 B-cell and plasmablast-derived IL-10 in the regulation of human cGVHD. ( Blood . 2015;125(11):1830-1839) Here, we prospectively studied Bregs and B-cell subsets in 69 AHSCT recipients. Our results suggest that Bregs are enriched in both the CD24 hi CD27 1 B-cell subset and CD24 2 CD27 hi CD38 hi plasmablast cell compartments. In vitro differentiation of human B cells into plasmablasts and plasma cells increased IL-10 – producing B-cell numbers. Allogeneic transplant recipients with cGVHD had decreased Bregs and IL-10 – producing plasmablast counts as compared with AHSCT recipients with no cGVHD. This suggests a novel role of CD24 hi CD27 1 B-cell – and plasmablast-derived IL-10 in the regulation of human cGVHD.

[1]  A. ElGhammaz Current issues in chronic graft versus host disease , 2015 .

[2]  K. Takeda,et al.  Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. , 2014, Immunity.

[3]  K. Rezvani,et al.  Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. , 2014, Blood.

[4]  J. Jagdeo,et al.  Treatment of chronic graft-versus-host disease with bortezomib. , 2014, Blood.

[5]  H. Li,et al.  Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10 , 2014, Leukemia.

[6]  D. Hafler,et al.  TLR‐mediated STAT3 and ERK activation controls IL‐10 secretion by human B cells , 2014, European journal of immunology.

[7]  J. Byrd,et al.  Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. , 2014, Blood.

[8]  V. D. Dang,et al.  From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets. , 2014, Current opinion in immunology.

[9]  Hyun-Dong Chang,et al.  Autocrine IL‐10 promotes human B‐cell differentiation into IgM‐ or IgG‐secreting plasmablasts , 2014, European journal of immunology.

[10]  Ellen Hilgenberg,et al.  B‐type suppression: A role played by “regulatory B cells” or “regulatory plasma cells”? , 2014, European journal of immunology.

[11]  J. Serody,et al.  Increased BCR responsiveness in B cells from patients with chronic GVHD. , 2014, Blood.

[12]  J. Casanova,et al.  IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts. , 2013, Blood.

[13]  J. Casanova,et al.  Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells , 2013, The Journal of experimental medicine.

[14]  A. Campos-Caro,et al.  STAT-3 Activation by Differential Cytokines Is Critical for Human In Vivo–Generated Plasma Cell Survival and Ig Secretion , 2013, The Journal of Immunology.

[15]  T. Huizinga,et al.  IL-21 Enhances the Activity of the TLR–MyD88–STAT3 Pathway but Not the Classical TLR–MyD88–NF-κB Pathway in Human B Cells To Boost Antibody Production , 2013, The Journal of Immunology.

[16]  J. Ritz,et al.  Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial. , 2013, Blood.

[17]  P. van Paassen,et al.  Regulatory B cells in ANCA-associated vasculitis , 2013, Annals of the rheumatic diseases.

[18]  J. Ritz,et al.  Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease , 2013, Science Translational Medicine.

[19]  Xiao-jun Huang,et al.  Donor Th17 cells and IL‐21 may contribute to the development of chronic graft‐versus‐host disease after allogeneic transplantation , 2013, European journal of immunology.

[20]  D. Isenberg,et al.  CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation , 2013, Science Translational Medicine.

[21]  J. Bussel,et al.  Defective regulatory B-cell compartment in patients with immune thrombocytopenia. , 2012, Blood.

[22]  J. Ritz,et al.  B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. , 2012, Blood.

[23]  W. Leonard,et al.  Regulatory B Cells Control T Cell Autoimmunity Through IL-21-Dependent Cognate Interactions , 2012, Nature.

[24]  V. Pascual,et al.  Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation , 2012, The Journal of experimental medicine.

[25]  C. Weaver,et al.  Regulatory B10 Cells Differentiate into Antibody-Secreting Cells After Transient IL-10 Production In Vivo , 2012, The Journal of Immunology.

[26]  S. Dillon,et al.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. , 2012, Blood.

[27]  P. Taylor,et al.  Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis. , 2011, Blood.

[28]  J. Ritz,et al.  Interleukin-2 and regulatory T cells in graft-versus-host disease. , 2011, The New England journal of medicine.

[29]  P. Youinou,et al.  Human T cells induce their own regulation through activation of B cells. , 2011, Journal of autoimmunity.

[30]  B. Falini,et al.  Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.

[31]  W. Pickl,et al.  Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. , 2011, Blood.

[32]  G. Socié Chronic GVHD: B cells come of age. , 2011, Blood.

[33]  J. Ritz,et al.  Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. , 2011, Blood.

[34]  T. Rothstein,et al.  Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− , 2011, The Journal of Experimental Medicine.

[35]  J. Wagner,et al.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.

[36]  E. S. St. Clair,et al.  Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. , 2011, Blood.

[37]  M. Bagot,et al.  IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro , 2010, European journal of immunology.

[38]  M. Robin,et al.  Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections , 2010, Haematologica.

[39]  M. Jourdan,et al.  An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. , 2009, Blood.

[40]  R. Storb,et al.  The role of B cells in the pathogenesis of graft-versus-host disease. , 2009, Blood.

[41]  J. Ritz,et al.  Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. , 2009, Blood.

[42]  A. Hagenbeek,et al.  B-cell involvement in chronic graft-versus-host disease , 2008, Haematologica.

[43]  I. Sanz,et al.  Phenotypic and functional heterogeneity of human memory B cells. , 2008, Seminars in immunology.

[44]  J. Ritz,et al.  High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease , 2007, Clinical Cancer Research.

[45]  S. Tangye,et al.  BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. , 2003, The Journal of clinical investigation.

[46]  Antonio Lanzavecchia,et al.  Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.

[47]  K. Rajewsky,et al.  Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells , 1998, The Journal of experimental medicine.

[48]  S. Tangye,et al.  Identification of Functional Human Splenic Memory B Cells by Expression of CD148 and CD27 , 1998, The Journal of experimental medicine.

[49]  D. Tarlinton,et al.  Kinetics of establishing the memory B cell population as revealed by CD38 expression. , 1998, Journal of immunology.

[50]  J. Banchereau,et al.  CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype , 1996, The Journal of experimental medicine.

[51]  H. Smits,et al.  Toll-like receptor ligation for the induction of regulatory B cells. , 2014, Methods in molecular biology.

[52]  J. Bouaziz,et al.  Purification and immunophenotypic characterization of human B cells with regulatory functions. , 2014, Methods in molecular biology.

[53]  J. Ritz,et al.  Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. , 2012, Blood.

[54]  Eren,et al.  The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.

[55]  M. Turner,et al.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.